A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis

角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂

基本信息

  • 批准号:
    10391450
  • 负责人:
  • 金额:
    $ 39.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Project Summary In our recently published work, we discovered that CUB-Domain-Containing Protein 1 (CDCP1) is a new and important ligand of CD6, which is a marker and a critical regulator of T cells, demonstrating a surprising role of CDCP1 in immune regulation. CDCP1 was originally discovered to be overexpressed on certain solid tumor cells, regulating tumor-cell anoikis resistance. However, the distribution of CDCP1 in the eye and its potential role in tissue homeostasis was unknown. In our latest (unpublished) work, using CDCP1 knockout (KO) mice and CDCP1 knocked down human corneal epithelial cells, we discovered that CDCP1 is highly and selectively expressed on corneal epithelial cells among all ocular cells, and that CDCP1 is critical for enhancing corneal wounding healing. In this proposed project, using the unique reagents and models that we have developed, including CDCP1-KO mice, CD6-KO mice, CDCP1-KO human corneal epithelial cells and recombinant mutant CDCP1 proteins, we will elucidate both the intrinsic and extrinsic mechanisms by which CDCP1 enhances corneal wound healing. We will also test novel CDCP1-targeted approaches as new therapeutics for accelerating corneal wound healing. The proposed work would establish a previously unknown role of CDCP1 in corneal wound healing, facilitate the development of new and effective therapies for this corneal pathological condition, and open a new avenue for research on CDCP1 and corneal homeostasis.
项目摘要 在我们最近发表的工作中,我们发现含有CUB结构域的蛋白1(CDCP 1)是CD 6的一种新的重要配体,CD 6是T细胞的标志物和关键调节因子,证明了CDCP 1在免疫调节中的惊人作用。CDCP 1最初被发现在某些实体瘤细胞上过表达,调节肿瘤细胞失巢凋亡抗性。然而,CDCP 1在眼睛中的分布及其在组织稳态中的潜在作用尚不清楚。在我们最新的(未发表的)工作中,使用CDCP 1敲除(KO)小鼠和CDCP 1敲除的人角膜上皮细胞,我们发现CDCP 1在所有眼细胞中高度选择性地表达在角膜上皮细胞上,并且CDCP 1对于增强角膜创伤愈合至关重要。在这个计划中,我们将使用我们开发的独特的试剂和模型,包括CDCP 1-KO小鼠,CD 6-KO小鼠,CDCP 1-KO人角膜上皮细胞和重组突变CDCP 1蛋白,我们将阐明CDCP 1促进角膜伤口愈合的内在和外在机制。我们还将测试新的CDCP 1靶向方法,作为加速角膜伤口愈合的新疗法。拟议的工作将建立CDCP 1在角膜伤口愈合中以前未知的作用,促进这种角膜病理状况的新的有效疗法的开发,并为CDCP 1和角膜稳态的研究开辟新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FENG C LIN其他文献

FENG C LIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FENG C LIN', 18)}}的其他基金

Role of CDCP1 in the pathogenesis of autoimmune uveitis
CDCP1在自身免疫性葡萄膜炎发病机制中的作用
  • 批准号:
    10655755
  • 财政年份:
    2023
  • 资助金额:
    $ 39.04万
  • 项目类别:
Development of a novel antibody-drug conjugate for treating T-cell lymphoma.
开发用于治疗 T 细胞淋巴瘤的新型抗体-药物缀合物。
  • 批准号:
    10545523
  • 财政年份:
    2022
  • 资助金额:
    $ 39.04万
  • 项目类别:
Development of a new drug for treating autoimmune uveitis
治疗自身免疫性葡萄膜炎新药的研制
  • 批准号:
    10321980
  • 财政年份:
    2021
  • 资助金额:
    $ 39.04万
  • 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
  • 批准号:
    10175270
  • 财政年份:
    2021
  • 资助金额:
    $ 39.04万
  • 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
  • 批准号:
    10397686
  • 财政年份:
    2021
  • 资助金额:
    $ 39.04万
  • 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
  • 批准号:
    10619536
  • 财政年份:
    2021
  • 资助金额:
    $ 39.04万
  • 项目类别:
A novel regulator of Pseudomonas aeruginosa keratitis
铜绿假单胞菌角膜炎的新型调节剂
  • 批准号:
    10618396
  • 财政年份:
    2020
  • 资助金额:
    $ 39.04万
  • 项目类别:
A novel regulator of Pseudomonas aeruginosa keratitis
铜绿假单胞菌角膜炎的新型调节剂
  • 批准号:
    10401830
  • 财政年份:
    2020
  • 资助金额:
    $ 39.04万
  • 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
  • 批准号:
    9898378
  • 财政年份:
    2019
  • 资助金额:
    $ 39.04万
  • 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
  • 批准号:
    10133084
  • 财政年份:
    2019
  • 资助金额:
    $ 39.04万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.04万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了